Financhill
Buy
74

TFII.TO Quote, Financials, Valuation and Earnings

Last price:
$136.78
Seasonality move :
10.05%
Day range:
$135.84 - $139.05
52-week range:
$102.57 - $219.48
Dividend yield:
1.83%
P/E ratio:
25.74x
P/S ratio:
1.03x
P/B ratio:
3.09x
Volume:
603.2K
Avg. volume:
257.1K
1-year change:
-35.81%
Market cap:
$11.4B
Revenue:
$11.5B
EPS (TTM):
$5.36

Earnings Data

Next earnings date for TFII.TO
Feb 19
2026
Most recent earnings per share
$1.41
Missed by $0.27
(Oct 30/2025)
Consensus Estimate
$1.68
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TFII.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/19/2026 Q4 $2.7B -- -- $1.20 --
10/30/2025 Q3 $2.8B $2.7B $1.41 $1.68 -$0.27
07/28/2025 Q2 $2.8B $2.8B $1.62 $1.69 -$0.07
04/23/2025 Q1 $2.8B $2.8B $0.95 $1.30 -$0.35
02/20/2025 Q4 $3.2B $2.9B $1.38 $2.32 -$0.95
10/21/2024 Q3 $3.1B $3B $2.02 $2.45 -$0.44
07/25/2024 Q2 $3.2B $3.1B $1.86 $2.21 -$0.36
04/25/2024 Q1 $2.6B $2.5B $1.47 $1.87 -$0.41
02/08/2024 Q4 $2.6B $2.7B $2.08 $2.25 -$0.16
10/23/2023 Q3 -- $2.6B $2.06 -- --
07/31/2023 Q2 -- $2.4B $1.98 -- --
04/25/2023 Q1 -- $2.5B $1.72 -- --
02/06/2023 Q4 -- $2.7B $2.36 -- --
10/27/2022 Q3 -- $2.9B $3.56 -- --
07/28/2022 Q2 -- $3.1B $3.83 -- --
04/28/2022 Q1 -- $2.8B $1.99 -- --
02/07/2022 Q4 -- $2.7B $1.92 -- --
10/28/2021 Q3 -- $2.6B $1.74 -- --
07/26/2021 Q2 -- $2.3B $5.30 -- --
04/27/2021 Q1 -- $1.5B $0.89 -- --
02/08/2021 Q4 -- $1.5B $1.19 -- --
10/22/2020 Q3 -- $1.2B $1.19 -- --
07/27/2020 Q2 -- $1.1B $0.79 -- --
04/21/2020 Q1 -- $1.2B $0.88 -- --
12/31/2019 Q4 -- $1.3B $0.92 -- --
09/30/2019 Q3 -- $1.3B $0.98 -- --
06/30/2019 Q2 -- $1.3B $1.01 -- --
03/31/2019 Q1 -- $1.2B $0.74 -- --
12/31/2018 Q4 -- $1.3B $0.85 -- --
09/30/2018 Q3 -- $1.3B $0.96 -- --
06/30/2018 Q2 -- $1.3B $0.89 -- --
03/31/2018 Q1 -- $1.2B $0.53 -- --
12/31/2017 Q4 -- $1.2B $1.31 -- --
09/30/2017 Q3 -- $1.2B $1.07 -- --
06/30/2017 Q2 -- $1.3B -$0.82 -- --
03/31/2017 Q1 -- $1.2B $0.15 -- --
12/31/2016 Q4 -- $1.1B $0.48 -- --
09/30/2016 Q3 -- $975.5M $0.55 -- --
06/30/2016 Q2 -- $977.8M $0.41 -- --
03/31/2016 Q1 -- $934.2M $0.13 -- --
12/31/2015 Q4 -- $872M $0.44 -- --

TFI International, Inc. Earnings Questions

  • How Much did TFI International, Inc. Generate in Revenue Last Quarter?

    TFI International, Inc. reported $2.7B worth of top line sales in its most recent quarter.

  • Did TFI International, Inc. Beat Earnings Last Quarter?

    TFI International, Inc. announced earnings per share of $1.41 which represents a miss of analyst forecast a $1.68 per share.

  • Is TFI International, Inc. Profitable?

    TFI International, Inc. reported $350.2M that represents $4.23 per share over the last quarter.

  • What is the Analyst Consensus for TFI International, Inc. EPS Next Year?

    TFI International, Inc.'s earnings are forecast to decrease from $6.79 per share to $9.02 per share next year representing a decrease of -13.83%.

  • When is TFI International, Inc.'s Earnings Date?

    TFI International, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock